Results 191 to 200 of about 39,316 (219)
Some of the next articles are maybe not open access.

Bortezomib

Reactions Weekly, 2016
  +6 more sources

Bortezomib

Reactions Weekly, 2013
  +4 more sources

Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial

Lancet, The, 2020
Sebastian Grosicki   +2 more
exaly  

Bortezomib

Reactions Weekly, 2018
  +4 more sources

Bortezomib

Reactions Weekly, 2023
openaire   +1 more source

Bortezomib

Reactions Weekly, 2015
  +4 more sources

Bortezomib

Reactions Weekly
  +4 more sources

Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma

New England Journal of Medicine, 2005
Paul G Richardson   +2 more
exaly  

Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma

New England Journal of Medicine, 2018
María-Victoria Mateos   +2 more
exaly  

Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial

Lancet, The, 2020
María-Victoria Mateos   +2 more
exaly  
multiple myeloma
diseases of the blood and blood-forming organs
medicine
neoplasms
tumors
oncology
including cancer and carcinogens
protease inhibitors
boronic acids
previous   18  19  20  21  22  

Home - About - Disclaimer - Privacy